McGill University Psilocybin Trial Shows Permanent Remission in Severe Depression
McGill University's Phase 3 trial reveals that a single dose of psilocybin combined with therapy induces sustained remis...
Read More →Breakthroughs in medical science and clinical trials.
McGill University's Phase 3 trial reveals that a single dose of psilocybin combined with therapy induces sustained remis...
Read More →University of Toronto researchers have developed a blood test that detects a specific pTDP-43 biomarker, predicting ALS ...
Read More →Imperial College London has engineered biodegradable DNA origami nanobots that deliver chemotherapy directly inside canc...
Read More →A massive 10-year UK Biobank study reveals that a diverse gut microbiome rich in SCFA-producing bacteria reduces the ris...
Read More →Oxford University researchers have successfully reversed Type 1 Diabetes in a clinical trial using immune-evasive, stem ...
Read More →UCSF researchers have developed a high-bandwidth Brain-Computer Interface that decodes neural speech intentions into tex...
Read More →MIT researchers have used advanced AI to discover ML-429, a novel antibiotic class that effectively kills drug-resistant...
Read More →A landmark Phase 3 trial reveals that a personalized mRNA neoantigen vaccine achieves a 90% recurrence-free survival rat...
Read More →The FDA has approved the first CRISPR gene therapy for Alzheimer's disease, targeting the APOE4 gene to halt cognitive d...
Read More →Scientists analyzing ancient DNA from Siberian hunter-gatherer cemeteries discovered that plague was killing humans 5,50...
Read More →